Research & Development



  霍去病听了霍光的話,笑著摸摸弟弟的腦袋道︰“好事情啊,總要所有人都富裕起來才解氣啊,到時候像阿襄這種狗都不吃的貴人全需要自己去種地,嗯,想想都開心,回去看看家里還有多少錢,全部拿去放貸,就兩成利。”   “我哪里知道!”色天使色姐妹在线视频   跟何不食肉糜有異曲同工之妙。caoprn超碰最新地址   一口氣擺出來了無數的例子,讓何愁有漲成豬肝色的面孔終于恢復了尋常顏色。   之要雲瑯在,甦稚就無所畏懼,開心的拿出自己從石屋里找到的三樣東西給雲瑯看。超碰视频在线   雲瑯冷笑道︰“你以為的殷實人家是什麼樣子的?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo